Improving the quality of care for inflammatory bowel disease

被引:14
作者
Ye, Byong Duk [1 ,2 ]
Travis, Simon [3 ]
机构
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Ctr Inflammatory Bowel Dis, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
[3] Oxford Univ Hosp, Translat Gastroenterol Unit, Oxford, England
关键词
Inflammatory bowel disease; Quality of care; Health system; Treat to target; 2ND ASIAN ORGANIZATION; WEB-BASED SURVEY; CROHNS-DISEASE; ULCERATIVE-COLITIS; THERAPEUTIC GOALS; DECISION-MAKING; HEALTH-CARE; INDICATORS; MANAGEMENT; CONSENSUS;
D O I
10.5217/ir.2018.00113
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Great strides have been achieved in the development of quality-of-care measures and standards for inflammatory bowel disease (IBD) over the last decade. The central structural component of care in IBD revolves around the multidisciplinary team, which should be equipped with the necessary resources to operate and implement decisions. Process measures have been defined by interest groups and can be adapted into process tools for the delivery of care for various patient subgroups and clinical scenarios. The emerging treat-to-target approach to IBD management may be used to achieve optimal long-term and holistic patient-centred outcomes, such as survival, control of inflammation and disease progression, symptomatic remission, quality of life and complications. Other important quality-of-care outcome measures for IBD include disutility of care, healthcare utilization and other patient-reported outcomes such as nutritional status and impact of fistulae. The current challenge for healthcare providers and health systems is the integration of quality-of-care structures and processes into clinical practice, and the consistent delivery of updated evidence-based quality IBD care to various patient populations by individual health care providers. Finally, the awareness and appreciation for quality of care in IBD is increasing in Asia, and Asian healthcare institutions should be encouraged to take the lead in improving the quality of care in IBD.
引用
收藏
页码:45 / 53
页数:9
相关论文
共 39 条
[1]   Review article: moving towards common therapeutic goals in Crohn's disease and rheumatoid arthritis [J].
Allen, P. B. ;
Olivera, P. ;
Emery, P. ;
Moulin, D. ;
Jouzeau, J. -Y. ;
Netter, P. ;
Danese, S. ;
Feagan, B. ;
Sandborn, W. J. ;
Peyrin-Biroulet, L. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (08) :1058-1072
[2]  
[Anonymous], 2001, CROSS QUAL CHASM NEW
[3]   Current and Future Targets for Mucosal Healing in Inflammatory Bowel Disease [J].
Atreya, Raja ;
Neurath, Markus F. .
VISCERAL MEDICINE, 2017, 33 (01) :82-88
[4]   Quality indicators in inflammatory bowel disease [J].
Berry, Sameer K. ;
Melmed, Gil Y. .
INTESTINAL RESEARCH, 2018, 16 (01) :43-47
[5]   Quality Improvement Initiatives in Inflammatory Bowel Disease [J].
Berry S.K. ;
Siegel C.A. ;
Melmed G.Y. .
Current Gastroenterology Reports, 2017, 19 (8)
[6]   Development and validation of a rapid, generic measure of disease control from the patient's perspective: the IBD-Control questionnaire [J].
Bodger, Keith ;
Ormerod, Clare ;
Shackcloth, Daniela ;
Harrison, Melanie .
GUT, 2014, 63 (07) :1092-1102
[7]   Endoscopic Assessment and Treating to Target Increase the Likelihood of Mucosal Healing in Patients With Crohn's Disease [J].
Bouguen, Guillaume ;
Levesque, Barrett G. ;
Pola, Suresh ;
Evans, Elisabeth ;
Sandborn, William J. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (06) :978-985
[8]   Limited uptake of ulcerative colitis "treat-to-target" recommendations in real-world practice [J].
Bryant, Robert V. ;
Costello, Samuel P. ;
Schoeman, Scott ;
Sathananthan, Dharshan ;
Knight, Emma ;
Lau, Su-Yin ;
Schoeman, Mark N. ;
Mountifield, Reme ;
Tee, Derrick ;
Travis, Simon P. L. ;
Andrews, Jane M. .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (03) :599-607
[9]   Delphi consensus statement: Quality indicators for Inflammatory Bowel Disease Comprehensive Care Units [J].
Calvet, Xavier ;
Panes, Julian ;
Alfaro, Noelia ;
Hinojosa, Joaquin ;
Sicilia, Beatriz ;
Gallego, Marta ;
Perez, Ildefonso ;
Lazaro y de Mercado, Pablo ;
Gomollon, Fernando ;
Aldeguer, Xavier ;
Alos, Rafael ;
Andreu, Montserrat ;
Barreiro, Manu ;
Bermejo, Fernando ;
Casis, Begona ;
Domenech, Eugeni ;
Espin, Eloy ;
Esteve, Maria ;
Garcia-Sanchez, Valle ;
Lopez-Sanroman, Antonio ;
Martinez-Montiel, Pilar ;
Luis Mendoza, Juan ;
Gisbert, Javier P. ;
Vera, Maribel ;
Dosal, Angelina ;
Sanchez, Elena ;
Marin, Laura ;
Sanroman, Luciano ;
Pinilla, Pilar ;
Murciano, Francisca ;
Torrejon, Antonio ;
Ramon Garcia, Jose ;
Ortega, Mayte ;
Roldan, Julio .
JOURNAL OF CROHNS & COLITIS, 2014, 8 (03) :240-251
[10]   Systematic review: the costs of ulcerative colitis in Western countries [J].
Cohen, R. D. ;
Yu, A. P. ;
Wu, E. Q. ;
Xie, J. ;
Mulani, P. M. ;
Chao, J. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 31 (07) :693-707